Merus N.V (NASDAQ: MRUS) on Tuesday, soared 1.27% from the previous trading day, before settling in for the closing price of $42.45. Within the past 52 weeks, MRUS’s price has moved between $27.11 and $61.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 7.00% over the last five years. The company achieved an average annual earnings per share of -27.62%. With a float of $58.58 million, this company’s outstanding shares have now reached $68.43 million.
The firm has a total of 229 workers. Let’s measure their productivity. In terms of profitability, gross margin is -4.25%, operating margin of -642.76%, and the pretax margin is -659.93%.
Merus N.V (MRUS) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Merus N.V is 14.43%, while institutional ownership is 91.21%. The most recent insider transaction that took place on Aug 21 ’24, was worth 135,000. In this transaction VP Controller, PAO of this company sold 2,500 shares at a rate of $54.00, taking the stock ownership to the 7,002 shares. Before that another transaction happened on Aug 20 ’24, when Company’s VP Controller, PAO sold 2,500 for $54.00, making the entire transaction worth $135,000. This insider now owns 7,002 shares in total.
Merus N.V (MRUS) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.94 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -27.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -13.30% during the next five years compared to -18.50% drop over the previous five years of trading.
Merus N.V (NASDAQ: MRUS) Trading Performance Indicators
Merus N.V (MRUS) is currently performing well based on its current performance indicators. A quick ratio of 8.32 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 81.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.91, a number that is poised to hit -0.96 in the next quarter and is forecasted to reach -3.87 in one year’s time.
Technical Analysis of Merus N.V (MRUS)
Analysing the last 5-days average volume posted by the [Merus N.V, MRUS], we can find that recorded value of 0.86 million was better than the volume posted last year of 0.68 million. As of the previous 9 days, the stock’s Stochastic %D was 28.59%. Additionally, its Average True Range was 2.06.
During the past 100 days, Merus N.V’s (MRUS) raw stochastic average was set at 9.61%, which indicates a significant decrease from 23.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.62% in the past 14 days, which was higher than the 36.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $47.74, while its 200-day Moving Average is $49.42. Now, the first resistance to watch is $43.13. This is followed by the second major resistance level at $43.86. The third major resistance level sits at $44.44. If the price goes on to break the first support level at $41.82, it is likely to go to the next support level at $41.24. Now, if the price goes above the second support level, the third support stands at $40.51.
Merus N.V (NASDAQ: MRUS) Key Stats
Market capitalization of the company is 2.94 billion based on 68,464K outstanding shares. Right now, sales total 43,950 K and income totals -154,940 K. The company made 11,770 K in profit during its latest quarter, and -99,910 K in sales during its previous quarter.
